ReviewTargeted oncology2023
Trastuzumab Deruxtecan: A Review in Unresectable or Metastatic HER2-Positive Breast Cancer.
Tina Nie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewTargeted oncology2023
Tina Nie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.